Scientific Breakthrough
Clear Market Focus
Advancing a lead program in uveal melanoma (UM) with liver metastasis.
Innovative Pipeline
Expansion to novel HDAC8 and other selective HDAC compounds.
Strategic Collaborations
Engaging with leading CROs, academic centers, and patient advocacy groups.